AlzeCure Pharma (Sweden) Analysis
| ALZCUR Stock | SEK 1.28 0.07 5.79% |
AlzeCure Pharma is overvalued with Real Value of 1.13 and Hype Value of 1.28. The main objective of AlzeCure Pharma stock analysis is to determine its intrinsic value, which is an estimate of what AlzeCure Pharma is worth, separate from its market price. There are two main types of AlzeCure Pharma's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect AlzeCure Pharma's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of AlzeCure Pharma's stock to identify patterns and trends that may indicate its future price movements.
The AlzeCure Pharma stock is traded in Sweden on Stockholm Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Sweden. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and AlzeCure Pharma's ongoing operational relationships across important fundamental and technical indicators.
AlzeCure |
AlzeCure Stock Analysis Notes
About 41.0% of the company shares are held by company insiders. The company recorded a loss per share of 1.78. AlzeCure Pharma had not issued any dividends in recent years. AlzeCure Pharma AB develops therapies for the treatment of Alzheimer s disease and related neurodegenerative disorders. The company was founded in 2012 and is based in Huddinge, Sweden. AlzeCure Pharma is traded on Stockholm Stock Exchange in Sweden. For more info on AlzeCure Pharma please contact the company at 46 8 52 80 03 99 or go to https://www.alzecurepharma.se.AlzeCure Pharma Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. AlzeCure Pharma's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding AlzeCure Pharma or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| AlzeCure Pharma generated a negative expected return over the last 90 days | |
| AlzeCure Pharma has high historical volatility and very poor performance | |
| AlzeCure Pharma may become a speculative penny stock | |
| AlzeCure Pharma has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (77.78 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| AlzeCure Pharma has accumulated about 222.05 M in cash with (70.64 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.88, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 41.0% of the company shares are held by company insiders |
AlzeCure Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 254.44 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AlzeCure Pharma's market, we take the total number of its shares issued and multiply it by AlzeCure Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 19th of January, AlzeCure Pharma shows the Mean Deviation of 3.7, standard deviation of 5.15, and Risk Adjusted Performance of (0.07). AlzeCure Pharma technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.AlzeCure Pharma Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. AlzeCure Pharma middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for AlzeCure Pharma. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
AlzeCure Pharma Outstanding Bonds
AlzeCure Pharma issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. AlzeCure Pharma uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most AlzeCure bonds can be classified according to their maturity, which is the date when AlzeCure Pharma has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View |
AlzeCure Pharma Predictive Daily Indicators
AlzeCure Pharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of AlzeCure Pharma stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
AlzeCure Pharma Forecast Models
AlzeCure Pharma's time-series forecasting models are one of many AlzeCure Pharma's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary AlzeCure Pharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About AlzeCure Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how AlzeCure Pharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling AlzeCure shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as AlzeCure Pharma. By using and applying AlzeCure Stock analysis, traders can create a robust methodology for identifying AlzeCure entry and exit points for their positions.
AlzeCure Pharma AB develops therapies for the treatment of Alzheimer s disease and related neurodegenerative disorders. The company was founded in 2012 and is based in Huddinge, Sweden. AlzeCure Pharma is traded on Stockholm Stock Exchange in Sweden.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding AlzeCure Pharma to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Equity Forecasting Now
Equity ForecastingUse basic forecasting models to generate price predictions and determine price momentum |
| All Next | Launch Module |
Complementary Tools for AlzeCure Stock analysis
When running AlzeCure Pharma's price analysis, check to measure AlzeCure Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AlzeCure Pharma is operating at the current time. Most of AlzeCure Pharma's value examination focuses on studying past and present price action to predict the probability of AlzeCure Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AlzeCure Pharma's price. Additionally, you may evaluate how the addition of AlzeCure Pharma to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |